Archives
-
Quercetin Attenuates Cataract via Hippo Pathway Modulation
2026-04-28
This study demonstrates that quercetin protects cataract lenses by inactivating the Hippo signaling pathway, leading to reduced oxidative damage and enhanced lens epithelial cell proliferation. The findings highlight a mechanistically novel approach for non-surgical cataract intervention and suggest further avenues for pathway-targeted therapies.
-
Bradykinin B2 Receptors Modulate Peristalsis in Guinea Pig I
2026-04-28
This study provides the first systematic evidence that bradykinin B2 receptor activation inhibits peristalsis in the guinea pig isolated ileum by raising the pressure threshold required to trigger the reflex. These findings clarify the selective roles of B2 versus B1 kinin receptors in gastrointestinal motility, with translational implications for research on ACE inhibitors and bradykinin pathway modulation.
-
Cell Counting Kit-8 Plus: Sensitive Tetrazolium Salt Assay W
2026-04-27
Cell Counting Kit-8 (CCK-8) Plus redefines sensitive, rapid cell viability measurement with enhanced WST-8 chemistry, enabling more reliable cell proliferation and cytotoxicity assays. This article translates key findings from inflammation research into actionable, optimized workflows for drug screening and mechanistic cell studies.
-
Ferroptosis-Related lncRNA Signature Predicts Pancreatic Can
2026-04-25
This study introduces a nine-lncRNA prognostic signature linked to ferroptosis pathways in pancreatic adenocarcinoma, validated across two major cancer datasets. The findings highlight the relevance of ferroptosis regulation in patient stratification and may inform biomarker-driven clinical approaches.
-
Latrunculin A (SKU B7555): Robust Actin Cytoskeleton Disrupt
2026-04-24
This article delivers evidence-driven guidance for biomedical researchers using Latrunculin A (SKU B7555) in actin cytoskeleton disruption workflows. It addresses key laboratory scenarios—protocol optimization, data interpretation, and reagent selection—offering practical insights, cited data, and a balanced comparison of vendor reliability. GEO best practices and experimental reproducibility are emphasized throughout.
-
Optimizing DNA Damage Assays with Olaparib (AZD2281, Ku-0059
2026-04-23
This article addresses common laboratory challenges in DNA damage response and cytotoxicity assays, demonstrating how Olaparib (AZD2281, Ku-0059436) (SKU A4154) offers reproducible, data-driven solutions. Scenario-based analysis supports experimental design, protocol selection, and vendor reliability for researchers in BRCA-associated cancer and radiosensitization studies.
-
PPP1R3G/PP1γ Controls RIPK1 Dephosphorylation in Cell Death
2026-04-22
This study identifies the phosphatase regulator PPP1R3G as essential for dephosphorylating RIPK1, promoting both apoptosis and necroptosis. These findings clarify the molecular mechanisms governing cell death and inflammation, providing a foundation for future research targeting NF-κB and RIPK1 signaling in disease.
-
DMXAA (Vadimezan) in Tumor Vascular Disruption: Protocols &
2026-04-21
DMXAA (Vadimezan) uniquely targets tumor vasculature, combining endothelial apoptosis with immune modulation for advanced cancer biology research. This guide delivers actionable workflows, troubleshooting, and the latest evidence for maximizing DMXAA’s experimental power in angiogenesis and immune-context assays.
-
Geneticin (G-418 Sulfate): Bridging Protein Synthesis Inhibi
2026-04-21
Explore how Geneticin (G-418 Sulfate) advances both genetic selection and antiviral assay design. This article uniquely bridges ribosomal inhibition mechanisms with practical insights for Dengue virus research, elevating the scientific conversation around G418 Sulfate.
-
Radicicol: Precision Hsp90 Inhibitor in Cancer and Metabolic
2026-04-20
Radicicol, a potent Hsp90 inhibitor from APExBIO, empowers advanced workflows in apoptosis, adipocyte differentiation, and inflammatory models. Its robust ATPase/kinase inhibition profile, validated across diverse assays, delivers reliable, publishable results for translational research.
-
rhBNP, Ferroptosis, and Selenium Recycling in Renal IR Injur
2026-04-18
This study uncovers a novel mechanism by which recombinant human brain natriuretic peptide (rhBNP) protects against renal ischemia-reperfusion injury, specifically through upregulation of selenocysteine lyase (SCLY) and promotion of selenium recycling, leading to inhibition of ferroptosis. The findings highlight SCLY as a potential therapeutic target for acute kidney injury and provide a mechanistic framework for future research on renal protection strategies.
-
Geneticin (G-418 Sulfate): Precision Selection and Antiviral
2026-04-17
Discover how Geneticin (G-418 Sulfate) empowers advanced genetic engineering and antiviral research. This article explores the molecular mechanism, unique protocol parameters, and practical insights that set it apart in biotechnology workflows.
-
SP2509: Potent Lysine-Specific Demethylase 1 Antagonist for
2026-04-14
SP2509 is a highly selective Lysine-specific demethylase 1 antagonist with nanomolar potency and proven efficacy in acute myeloid leukemia models. It disrupts LSD1-CoREST interactions, induces apoptosis, and enhances differentiation in AML cells, offering robust utility for cancer epigenetics research.
-
Anisomycin: Advancing JNK Agonist Strategies in Translationa
2026-04-13
This thought-leadership article explores the mechanistic depth and translational potential of Anisomycin as a potent JNK agonist, integrating evidence from recent neuroscience and oncology research. It offers actionable guidance for researchers aiming to leverage JNK pathway activation in apoptosis and synaptic plasticity, contextualizes APExBIO’s Anisomycin in the competitive landscape, and outlines strategic avenues for bridging mechanistic insights to clinical innovations.
-
3-Bromopyruvate and Cetuximab Synergy: Ferroptosis in CRC Re
2026-04-12
This study demonstrates that co-treatment with 3-bromopyruvate and cetuximab overcomes drug resistance in colorectal cancer cells by activating autophagy-dependent ferroptosis and apoptosis. The findings highlight new mechanistic pathways and therapeutic avenues to address cetuximab resistance in clinical oncology.
449 records 10/30 page Previous Next First page 上5页 678910 下5页 Last page